Lecture 23.2: COVID Flashcards

1
Q

What is the disease progression fo COVID?

A
  • Stage I: Early Infection [HIGHEST viral response]
  • Stage II: Pulmonary [LOWEST viral and inflammatory]
  • Stage III: Hyperinflammation [HIGEST inflammatin response]

Stage I is normal 7 day?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Within the Infectious Disease Society of America Guidelines, when should you use and not use Glucocrticoids?

A
  • Recommends: Dexamethasone for critically ill
  • Suggests: Dexamethasone for severe, but non-critical
  • Sugguest against Dexamethasone for mild-to-mod COVID`
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Within the Infectious Disease Society of America Guidelines, when should you use and not use Inhaled Corticosteroids?

A
  • Suggest Against
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Within the Infectious Disease Society of America Guidelines, when should you use and not use Interleukin 6 Inhibitor?

A
  • Suggest: Tocilizumab for Severe or critical COVID with inflammation
  • Suggest: Sarilumab when Tocilizumab not available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Within the Infectious Disease Society of America Guidelines, when should you use and not use Remdesivir?

A
  • Suggests: For mild-mod; initiated Within 7 days of symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Remdesivir?

A
  • PRODRUG
  • MOA: Interferes with viral RNA-dependent RNA Poly; delayed chain rerminatino of viral RNA transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is important to know about the safety of Remdesivir?

A
  • Sulfobutylether-beta cyclodextrin [SBECD]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Within the Infectious Disease Society of America Guidelines, when should you use and not use Baricitinib?

A
  • Suggest: Severe COVID with cortocsteroids rather than no baricitinib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Within the Infectious Disease Society of America Guidelines, when should you use and not use Nirmatrelvir/Ritonavir [Paxlovid]?

A
  • Suggest: mild-mod; initiated Within 5 days of symptoms

NO significant decrease in mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Within the Infectious Disease Society of America Guidelines, when should you use and not use Molnupiravir?

A
  • Suggest: mild-mod; initiated within 5 days o symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly